Brain Organoid Biocomputing Explained (2026)
How brain organoid biocomputing works in 2026: culturing neural organoids, electrode interfaces, training signals, and the honest limits of wetware compute.
Cryo-EM Meets AI: Structure Prediction in Drug Discovery
How cryo-EM and AI structure prediction work together in 2026 drug discovery — the pipeline, what AlphaFold-class models add, and the honest limitations.
mRNA Beyond Vaccines: Programmable Therapeutics Explained
mRNA beyond vaccines — how programmable therapeutics work, lipid nanoparticle delivery, the manufacturing platform, and the real limits today.
AlphaFold 3 and Protein Structure Prediction Explained
AlphaFold 3 explained — how the diffusion-based model predicts protein, DNA, and ligand structures, why it matters, and its real limitations.
Cell-Free Biomanufacturing: Engineering Protein Production Without Living Cells
How cell-free biomanufacturing systems produce proteins and enzymes without living organisms. TX-TL systems, lysate preparation, reaction engineering, and industrial scale-up challenges.